Andrzej Januszewicz

机构：Hypertension Institute, Institute of Cardiology, Narodowy Instytut Leków · ORCID：0000-0002-1831-250X

发表论文 644 篇 · 总被引 21027 次 · h-index 61

代表论文

• 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension (2024 · European Journal of Internal Medicine · 被引 247)
• Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline (2024 · European Journal of Endocrinology · 被引 35)
• Malignant Hypertension:A Systemic Cardiovascular Disease (2024 · Journal of the American College of Cardiology · 被引 30)
• Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial (2026 · The Lancet · 被引 26)
• Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study (2024 · The Journal of Applied Laboratory Medicine · 被引 19)
• Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines (2024 · Hypertension · 被引 18)